Poland· PL-100096161
Maxibiotic
A other antibiotics for topical use product containing neomycini sulfas + bacitracinum zincum + polymyxini b sulfas, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Neomycini sulfas + bacitracinum zincum + polymyxini b sulfas is registered in 4 of 19 countries.
Countries holding a registration under ATC D06AX (other antibiotics for topical use), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Neomycini sulfas + bacitracinum zincum + polymyxini b sulfas · ATC D06AX
4 / 19 countries
- Belgiumprice
- Czechiaprice
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Neomycini sulfas + Bacitracinum zincum + Polymyxini B sulfas
- Manufacturer
- Bausch Health Ireland Ltd.
- Country
- Poland (PL)
- ATC code
- D06AX
- ATC class
- Other antibiotics for topical use
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991230074
- gtin05909990666065
- gtin05909990666072
- gtin05909990822515
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Neomycini sulfas + bacitracinum zincum + polymyxini b sulfas in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5f046bf0-eb5b-4473-9245-062aad0399b8 GET /v1/drugs/5f046bf0-eb5b-4473-9245-062aad0399b8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "(5 mg + 5000 j.m. 400 j.m.)/g",
"packaging": "05909990666065 ¦ OTC ¦ 2365\n1 tuba 3 g\n05909990666072 ¦ OTC ¦ 4720\n1 tuba 5 g\n05909990822515 ¦ OTC ¦ 16036\n1 tuba 15 g\n05909991230074 ¦ OTC ¦ 109504\n10 sasz. 1 g",
"substance": "Neomycini sulfas 5 mg + Bacitracinum zincum 5000 j.m. + Polymyxini B sulfas 400 j.m.",
"common_name": "Neomycini sulfas + Bacitracinum zincum + Polymyxini B sulfas",
"pl_product_id": "100096161",
"pozwolenie_nr": "08225",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about neomycini sulfas + bacitracinum zincum + polymyxini b sulfas.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.